Mader G, Mladsi D, Sanon M, Purser M, Barnett CL, Oberdhan D, Watnick T, Seliger S. A disease progression model estimating the benefit of tolvaptan on time to end-stage renal disease for patients with rapidly progressing autosomal dominant polycystic kidney disease. BMC Nephrol. 2022 Oct 18;23(1):334. doi: 10.1186/s12882-022-02956-8
Barnett CL, Denton BT. Optimization of biomarker-based prostate cancer screening policies. In: Sze-chuan Suen, David Scheinker, Eva Enns, editors. Artificial intelligence for healthcare: interdisciplinary partnerships for analytics-driven improvements in a post-COVID world. Cambridge: United Kingdom. Cambridge University Press; 2022. p.141-58.